The rationale behind this study was the lack of previously reported in vivo imaging studies of PNS involvement in MS, coupled with the potential role of MTR in this context, which has previously been demonstrated in the CNS to be directly influenced by the amount of myelin in neural tissue. The gene discussed is MTR; the disease is myeloid sarcoma.